This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Viruses have become a regular part of basic biological research as well as clinical therapy. These biological tools are useful because they ’ re derived from viruses that can infect people, cells, and animals. Some of these viruses are completely inert, but others can cause diseases. Nervous about handling viruses? That ’ s okay!
Pre-made viruses have become increasingly accessible and are useful for saving time and avoiding potentially costly set-ups. However, there are many cases where the specific viral particles you need are not available, or the cost of custom viruses are too high for your budget. In those cases, you’ll need to produce your viruses in-house.
Here we will discuss the four most commonly used lab viruses: gamma-retrovirus, lentivirus, adenovirus, and adeno-associated virus. There are a lot of viruses out there – most of which we would all like to steer clear of!
Viruses are simple – a genome packaged in a protein shell (Taylor, 2014). They’re so simple that we can’t even decide if they’re alive or not. Yet these simple, small particles have quite the outsized impact – and not just on the disease front.
In this blog we will review how these indicators work, their general applications, and why viruses are essential to their use as biological tools. Cellular activities like action potentials, muscle contractions, and the control of voltage gated ion channels all depend on transmitting and sensing electrical potential.
In this blog we will review the basics of biosensors and how to use viruses to set up these systems. Or maybe it’s a biosensor?! You can do more than just ‘sense’ biological compounds and reactions; you can quantify them with biosensors!
The blood-brain-barrier (BBB) exists to prevent substances in the blood, like proteins and viruses, from crossing into the brain. While helpful from a biological standpoint, it makes delivering AAVs to the brain difficult.
Adeno-associated viruses (AAV) are an important biological tool that allow scientists to express a gene of interest in a cell or animal model. AAV plasmids contain several important elements, but among the most important are the inverted terminal repeats (ITRs). ITRs are the elements that make an AAV plasmid an AAV plasmid.
Once ~400 cases had amassed in places around the world, hypotheses began to develop that this illness was caused by either SARS-CoV-2, Adenovirus type 41 (AdV-41), or Adenovirus-Associated Virus type 2 (AAV2) – or some unprecedented combination of the three (Servellita et al.,
So, if you’ve ever wondered what goes into ‘making virus’ or what gag and pol stand for, we demystify all components of viral vectors here! For safety and production reasons, multiple plasmids with many components are used to package lab grown viruses. It can be intimidating at first to look at so many plasmid maps and protocols!
As editor of Addgene’s eBooks — including the recently released Viral Vectors 101 2 nd edition — I was incredibly excited when we picked our viral vector service as one of those stories.
While it is tempting to just dive right in and start injecting your virus, a successful AAV experiment starts with validation and optimization. Using AAV vectors in complex biological systems can be tricky at best, and downright infuriating at worst.
What do a viral vector production facility, food allergy testing lab, and the grad student down the hall from you have in common? All of them rely on standard curves in their day-to-day work.
Air filtration units were widely used during large wildfire outbreaks in the western United States,[1] and their use surged nationwide during the COVID-19 pandemic as a way to reduce exposure to aerosols containing the SARS-CoV-2 virus.
Unfortunately, the road towards treatment can be time-consuming, especially when utilizing assays with live virus. Additionally, procuring the live virus for an evaluation assay is very difficult and labor intensive. Such high safety measures, although essential, can extend the timing of the development of a vaccine.
Adeno-associated virus (AAV) is a single stranded, Parvoviridae DNA virus, packaged in a non-enveloped icosahedral capsid, that can be used to express genes of interest in cell and animal models. This post was contributed by guest blogger Didem Goz Ayturk with edits and updates from Addgenies Karen Guerin and Susanna Stroik.
The complex relationship between a virus and its host is one of the hottest topics in science right now, and has been given considerable attention in recent weeks as a result of the race to understand the virus that causes COVID-19 and its potential vulnerabilities.
Avian influenza A viruses are classified into the following two categories: Highly pathogenic avian influenza (HPAI) virus strains are extremely infectious, often fatal to chickens, and can spread rapidly from flock-to-flock. Avian influenza (bird flu) is caused by infection with avian influenza (flu) Type A viruses.
To help make the process for scientists more accessible, we’re spotlighting a few of the GPU-accelerated applications that developers can use right now in the fight against this virus. Those compounds are likely to bind to the glycosylated spike (S) protein, which is how the virus enters host cells.
Because SARS-CoV-2 is so highly infectious, basic researchers without access to specially designed biosafety facilities may be limited in their ability to study the virus. While the quantum dots may bind and enter human cells just like the virus, they can’t cause an infection. But these harmless quantum dots offer a safe workaround.
In this blog, we summarize the growth, risks, and regulatory requirements for gene therapy research. Viral infection involves the transfer of the virus’ genetic material to host cells, making viruses ideal tools for gene transfer—once the genes responsible for viral replication and disease are removed.
For gene therapy vectors, this testing encompasses production cell lines, master and working cell banks (MCB, WCB), and virus banks. Depending on the gene therapy vector, microbial systems may be employed to produce vector DNA (such as in adeno associated virus (AAV)), in which case there may be bacterial cell banks and plasmid banks.
To learn more about our experience with the eSTAR for 510(k)s, check out our previous blogs ( here , here ). Note, however, that there is a virus scanning and technical screening process that will still happen. Make sure you submit your application using the most up-to-date version of eSTAR, as FDA frequently updates eSTAR templates.
There are three primary vectors employed in gene therapy: adeno-associated virus (AAV), adenovirus, or lentivirus vectors. Image Blog-Thumbnail_The-Altascientist-issue-36.jpg Some therapies are considered both cell and gene therapies, as they alter genes in specific types of cells.
At the same time, it is understandably important to be able to measure and characterize a treatment’s effect over time. However, with this most recent approval, FDA did not leave the question of durability as something to be answered postapproval, which signals to us that this issue looms large in FDA’s preapproval regulation of gene therapies.
Another promising strategy is drugs that target the proteins within human cells that the virus needs to infect, multiply, and spread. These studies narrowed the list to 73 human proteins that the virus depends on to replicate. That’s the strategy employed by remdesivir , the only antiviral drug currently authorized by the U.S.
A syndemic of opioid overdose, human immunodeficiency virus (HIV), hepatitis C virus (HCV), skin and soft tissue infections (SSTI), and infective endocarditis accounts for many of the poor health outcomes among PWUH [ 2 , 3 , 4 , 5 ]. Heroin can be consumed in several ways, including injection and smoking [ 6 ]. McMahan, V.M.,
BLZ945 decreases the growth of malignant cells in the mouse mammary tumor virus-driven polyomavirus middle T antigen (MMTV-PyMT) model of mammary carcinogenesis. BLZ945 attenuates the turnover rate of TAMs while increasing the number of CD8+ T cells that infiltrate cervical and breast carcinomas. ES/MS m/z 398.1(MH 3 : 100091.
Services will include the production and publication of investor bulletins, distribution of investor bulletins to the Consultant’s e-mail list, and posts via the Consultant’s blogs and social media accounts. In consideration of these services, the Company has paid the Consultant a fee of US$50,000 for a 6-month contract.
ACE2 is the receptor that the virus uses to gain entry. It’s a paper published in the journal Science [1] that presents an atomic-scale snapshot showing the 3D structure of the spike protein on the novel coronavirus attached to a human cell surface protein called ACE2, or angiotensin converting enzyme 2.
viral transmission of Human immunodeficiency virus (HIV) and Hepatitis C (HCV) through shared drug use equipment, fatal and nonfatal overdose), rather than exclusively targeting drug consumption itself [ 3 , 4 , 5 , 6 , 7 ]." Thus, practical strategies are necessary to reduce health-related harms associated with drug use (e.g.,
[link] [6] PHARMACOLOGY/TOXICOLOGY NDA REVIEW AND EVALUATION Study NC219 [link] [7] Acute Liver Injury due to Glecaprevir/Pibrentasvir in a Patient with Chronic Hepatitis C Virus Infection without Cirrhosis. link] Take a look at our other blogs The post Metabolism of macrocyclic drugs appeared first on Hypha Discovery.
[link] [6] PHARMACOLOGY/TOXICOLOGY NDA REVIEW AND EVALUATION Study NC219 [link] [7] Acute Liver Injury due to Glecaprevir/Pibrentasvir in a Patient with Chronic Hepatitis C Virus Infection without Cirrhosis. link] Take a look at our other blogs The post Metabolism of de novo designed macrocyclic drugs appeared first on Hypha Discovery.
18 The average cost of a hepatitis A–related hospitalization in 2016 was $16 610, and recent hepatitis A virus outbreaks alone have cost the nation at least $270 million since 2016. The estimated cost of providing health care services to persons living with chronic HCV infection is $15 billion annually.
Approximately 76% of HIV-patients with measurable viral load are infected with a strain of virus that is resistant to one or more classes of antiretroviral agents, thus reducing treatment options. AMD-070 targets the CXCR4 receptor on HIV and prevents the virus from entering and infecting healthy cells.
In this blog, we give you the answer. Read our recent blog to find out why you shouldn’t hesitate to put together your application, right now! That’s why we created the Research & Innovation (R&I) Conference over 5 years ago, now one of ELRIG’s renowned flagship events. But what is Research & Innovation?
Golub and colleagues produced the library by using a virus to insert a distinct DNA barcode, just 24 nucleotides long, stably into the genomes of each genetically distinct tumor cell line. This innovative research was led by the lab of Todd Golub of the Broad Institute of MIT and Harvard, Cambridge, MA. PRISM consists of two key components.
HbA1c, diagnosis of a particular virus, etc.). Therefore, instead of a general tool-type indication for collection of a sample matrix (e.g., saliva, capillary blood), separate clearances are often required for each application (e.g., As a thought experiment, consider what the state of the U.S.
Individuals with 2 APOL1 risk alleles are at increased risk of developing primary (idiopathic) FSGS, human immunodeficiency virus (HIV)-associated FSGS, and NDKD. Human genetics support a causal role for the G1 and G2 APOL1 variants in inducing kidney disease. The slurry was cooled to 5° C. and allowed to stir. 19 (8): 479–480.
The virus SARS-CoV-2 emerged in Wuhan, home of a premiere research institute that focuses on viruses. An altered virus could have escaped. Evidence that the virus emerged, or escaped, from the wildlife trade is lacking. Her points: 1. Coincidence? I’ve never thought so. RaTG13 shares about 96.1%
Although the novel coronavirus is the subject of nearly every media story right now, several years ago it was the Zika virus (ZIKV) gathering a great deal of attention. Here, we describe the novel use of high content imaging solutions (HCS) in a study to identify possible Zika virus inhibitors that could be translated into therapeutic form.
1 heavy chain (1-456) (human vh (homo sapiens ighv1-69*01(ighd)-ighj4*01 (90.1%)) (8.8.19) (1-126) -homo sapiens ighg1*03 Immunoglobulin g1, anti-(human respiratory syncytial virus fusion protein)(human monoclonal med18897.gamma.1-chain), 2] [3] Nirsevimab is designed to bind to the fusion protein on the surface of the RSV virus. [4]
The virus, which can cause a severe form of pneumonia and lead to acute respiratory distress, currently has no FDA-approved targeted therapeutic or vaccine. For this reason, researchers around the globe are scrambling to understand this novel virus and figure out its potentially targetable vulnerabilities.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content